Caroline Stokke

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Pluripotent Stem Cells

Positron Emission Tomography

Top Venues

European journal of nuclear medicine and molecular imaging

Pediatric radiology

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix Manuel Mottaghy, Jonathan Gear
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European journal of nuclear medicine and molecular imaging 51 (5) (2024)
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix Manuel Mottaghy, Jonathan Gear
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European journal of nuclear medicine and molecular imaging 51 (5) (2024)
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix Manuel Mottaghy, Jonathan Gear
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European journal of nuclear medicine and molecular imaging 51 (5) (2024)
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix Manuel Mottaghy, Jonathan Gear
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European journal of nuclear medicine and molecular imaging (2024)
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix Manuel Mottaghy, Jonathan Gear
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European journal of nuclear medicine and molecular imaging 51 (5) (2024)
Caroline Stokke, Silvano Gnesin, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix Manuel Mottaghy, Jonathan Gear
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European journal of nuclear medicine and molecular imaging 51 (5) (2024)
Ragnar Bruvoll, Johan Blakkisrud, Lars Tore Mikalsen, James Patrick Connelly, Caroline Stokke
Correlations between [ 68 Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [ 177 Lu]Lu-DOTA-TATE. Cancers 15 (4) (2023)
Susmita Afroz, Bjørn Helge Østerås, Utheya S Thevathas, Gaute Dohlen, Caroline Stokke, Trude E Robsahm, Hilde M Olerud
Use of ionizing radiation in a Norwegian cohort of children with congenital heart disease: imaging frequency and radiation dose for the Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Pediatrics (HARMONIC) study. Pediatric radiology (2023)
Ragnar Bruvoll, Johan Blakkisrud, Lars Tore Mikalsen, James Patrick Connelly, Caroline Stokke
Correlations between [ 68 Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [ 177 Lu]Lu-DOTA-TATE. Cancers 15 (4) (2023)
Ragnar Bruvoll, Johan Blakkisrud, Lars Tore Mikalsen, James Patrick Connelly, Caroline Stokke
Correlations between [ 68 Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [ 177 Lu]Lu-DOTA-TATE. Cancers 15 (4) (2023)
Caroline Stokke, Monika Kvassheim, Johan Blakkisrud
Radionuclides for Targeted Therapy: Physical Properties. Molecules (Basel, Switzerland) 27 (17) (2022)
Caroline Stokke, Jakob Nordberg Nørgaard, Hilde Feiring Phillips, Alexander Sherwani, Syed Nuruddin, James Connelly, Fredrik Schjesvold, Mona-Elisabeth Revheim
Comparison of [ 18 F]fluciclovine and [ 18 F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients. Molecular imaging and biology 24 (5) (2022)
Johan Blakkisrud, Ayca Løndalen, Jostein Dahle, Anne Catrine Martinsen, Arne Kolstad, Caroline Stokke
Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable. Acta oncologica (Stockholm, Sweden) 60 (11) (2021)
Ebba Gløersen Müller, Trine Holt Edwin, Caroline Stokke, Sigrid Stensby Navelsaker, Almira Babovic, Nenad Bogdanovic, Anne-Brita Knapskog, Mona Elisabeth Revheim
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic. PloS one 14 (8) (2019)
Caroline Stokke, Johan Blakkisrud, Ayca Løndalen, Jostein Dahle, Anne C T Martinsen, Harald Holte, Arne Kolstad
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients. European journal of nuclear medicine and molecular imaging 45 (7) (2018)
Caroline Stokke, Pablo Minguez Gabiña, Pavel Solný, Francesco Cicone, Mattias Sandström, Katarina Sjögreen Gleisner, Carlo Chiesa, Emiliano Spezi, Maria Paphiti, Mark Konijnenberg, Matt Aldridge, Jill Tipping, Michael Wissmeyer, Boudewijn Brans, Klaus Bacher, Carsten Kobe, Glenn Flux
Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force. EJNMMI physics 4 (1) (2017)